SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-006830
Filing Date
2021-02-04
Accepted
2021-02-04 17:24:59
Documents
42
Period of Report
2020-11-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1120_bespokeextracts.htm 10-Q 427087
2 CERTIFICATION f10q1120ex31-1_bespoke.htm EX-31.1 9418
3 CERTIFICATION f10q1120ex32-1_bespoke.htm EX-32.1 4205
  Complete submission text file 0001213900-21-006830.txt   2298161

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bspk-20201130.xml EX-101.INS 211171
5 XBRL SCHEMA FILE bspk-20201130.xsd EX-101.SCH 32600
6 XBRL CALCULATION FILE bspk-20201130_cal.xml EX-101.CAL 22241
7 XBRL DEFINITION FILE bspk-20201130_def.xml EX-101.DEF 172786
8 XBRL LABEL FILE bspk-20201130_lab.xml EX-101.LAB 300768
9 XBRL PRESENTATION FILE bspk-20201130_pre.xml EX-101.PRE 177655
Mailing Address 323 SUNNY ISLES BOULEVARD SUITE 700 SUNNY ISLES FL 33160
Business Address 323 SUNNY ISLES BOULEVARD SUITE 700 SUNNY ISLES FL 33160 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52759 | Film No.: 21592364
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences